LETTER
The emergence of heterogeneously glycopeptide-intermediate staphylococci (hGIS) has been linked to increasing therapeutic difficulties in sternal wound infections caused by methicillin-resistant Staphylococcus aureus (1, 2). Staphylococci with the hGIS phenotype appear susceptible to vancomycin in routine susceptibility testing, but a small subset of the population has decreased susceptibility. This has been proposed to be a precursor state to intermediate vancomycin resistance (3). In Sweden, coagulase-negative staphylococci (CoNS) are the staphylococci most commonly causing sternal wound infections after cardiac surgery (4). The hGIS phenotype is not well studied for CoNS, although a few studies have indicated their relevance (5, 6). High rates (77.9%) of Staphylococcus epidermidis isolates displaying the hGIS phenotype have been reported for isolates from patients with prosthetic joint infections at Swedish hospitals (7), and there is a need to investigate the prevalence and clinical significance of hGIS among CoNS in other types of infections.
CoNS were isolated from 60 out of 97 patients with revision surgery at the thoracic surgery unit at the University Hospital in Linköping, Sweden, between 2011 and 2014. Twenty-nine unique isolates from 20 patients were randomly selected and retrospectively evaluated. The isolates were tested for antimicrobial susceptibility with disc diffusion or Etest, mecA or mecC genotype with real-time PCR, species with matrix-assisted laser desorption–ionization time of flight (MALDI-TOF) mass spectrometry, and hGIS status with the population analysis profile-area under the curve (PAP-AUC) method. Associations between investigated parameters were tested using Fisher's exact test.
Phenotype and genotype prevalence data are presented in Table 1. No isolate was linezolid or daptomycin resistant, suggesting their potential therapeutic usefulness, although daptomycin resistance in S. aureus has been observed to emerge in vivo without drug exposure (8). The hGIS phenotype was detected in 21 (72%) isolates and among 15 (75%) of the patients. Although the hGIS phenotype among CoNS has been associated with a higher prevalence of multidrug resistance (MDR) and methicillin resistance (7), neither MDR, methicillin resistance, nor mecA was significantly associated with hGIS in the data collected in this study (Table 1). The isolates were S. epidermidis (n = 26), Staphylococcus capitis (n = 2), and Staphylococcus hominis (n = 1). None of the S. capitis or S. hominis isolates were determined to be hGIS. The vancomycin MIC for 93% of the isolates was 2.0 mg/liter, and none of the isolates were determined to be vancomycin resistant; however, single colonies among nine hGIS isolates were observed to grow on agar with a vancomycin concentration of 32 mg/liter or higher (up to 128 mg/liter). After isolation and reculturing of bacteria from these colonies, the MIC values for four isolates were higher (up to 8 mg/liter) than those for the main population.
TABLE 1.
Prevalence of resistance phenotypes and genotypes among coagulase-negative staphylococcia
Antibiotic or gene | No. (%) of resistant isolates |
Total (%) (n = 29) | |
---|---|---|---|
hGIS (n = 21)b | Non-hGIS (n = 8) | ||
Cefoxitin | 15 (71) | 6 (75) | 21 (72) |
Erythromycin | 12 (57) | 5 (63) | 17 (59) |
Clindamycin | 11 (52) | 5 (63) | 16 (55) |
Fusidic acid | 10 (48) | 1 (13) | 11 (38) |
Tobramycin | 13 (62) | 6 (75) | 19 (66) |
Gentamicin | 13 (62) | 4 (50) | 17 (59) |
Norfloxacin | 16 (76) | 5 (63) | 21 (72) |
Moxifloxacin | 5 (24) | 2 (25) | 7 (24) |
Rifampin | 2 (10) | 3 (38) | 5 (17) |
Linezolid | 0 | 0 | 0 |
Daptomycin | 0 | 0 | 0 |
MDRc | 16 (76) | 6 (75) | 22 (76) |
mecA | 16 (76) | 5 (63) | 21 (72) |
mecC | 0 | 0 | 0 |
Resistance breakpoints were used as defined by the European Committee for Antimicrobial Susceptibility Testing (EUCAST).
hGIS, heterogeneously glycopeptide-intermediate staphylococci.
MDR, multidrug resistant. Isolates were considered multidrug resistant if they were resistant to at least three different classes of antibiotics.
In this study, we observed a high prevalence of hGIS and MDR among CoNS isolates from sternal wounds together with a tentative increase in MICs for colonies exposed to growth media containing vancomycin for a subset of isolates. This emphasizes the need to further investigate the prevalence of hGIS among CoNS and the risk for selection of these organisms with suboptimal dosing. To avoid the overuse of vancomycin and thus the potential of promoting vancomycin resistance, the possibility of using other antimicrobials for treatment of sternal wound infections caused by staphylococci should be considered.
REFERENCES
- 1.Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis 38:448–451. doi: 10.1086/381093. [DOI] [PubMed] [Google Scholar]
- 2.Howden BP, Johnson PD, Ward PB, Stinear TP, Davies JK. 2006. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 50:3039–3047. doi: 10.1128/AAC.00422-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hiramatsu K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 1:147–155. doi: 10.1016/S1473-3099(01)00091-3. [DOI] [PubMed] [Google Scholar]
- 4.Söderquist B. 2007. Surgical site infections in cardiac surgery: microbiology. APMIS 115:1108–1111. [DOI] [PubMed] [Google Scholar]
- 5.Sieradzki K, Roberts RB, Serur D, Hargrave J, Tomasz A. 1999. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J Clin Microbiol 37:39–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rasigade JP, Raulin O, Picaud JC, Tellini C, Bes M, Grando J, Ben Saïd M, Claris O, Etienne J, Tigaud S, Laurent F. 2012. Methicillin-resistant Staphylococcus capitis with reduced vancomycin susceptibility causes late-onset sepsis in intensive care neonates. PLoS One 7:e31548. doi: 10.1371/journal.pone.0031548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tevell S, Claesson C, Hellmark B, Söderquist B, Nilsdotter-Augustinsson Å. 2014. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections. Eur J Clin Microbiol Infect Dis 33:911–917. doi: 10.1007/s10096-013-2025-3. [DOI] [PubMed] [Google Scholar]
- 8.Mishra NN, Yang SJ, Chen L, Muller C, Saleh-Mghir A, Kuhn S, Peschel A, Yeaman MR, Nast CC, Kreiswirth BN, Crémieux AC, Bayer AS. 2013. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms. PLoS One 8:e71151. doi: 10.1371/journal.pone.0071151. [DOI] [PMC free article] [PubMed] [Google Scholar]